Last update 01 Nov 2024

Lumateperone Tosylate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Lumateperone, Lumateperone tosylate (USAN), ITI-007
+ [2]
Mechanism
5-HT2A receptor antagonists(Serotonin 2a (5-HT2a) receptor antagonists), D2 receptor antagonists(Dopamine D2 receptor antagonists)
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
US (20 Dec 2019),
RegulationFast Track (US)
Login to view timeline

Structure

Molecular FormulaC31H36FN3O4S
InChIKeyLHAPOGAFBLSJJQ-GUTACTQSSA-N
CAS Registry1187020-80-9

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Bipolar Disorder
US
17 Dec 2021
Schizophrenia
US
20 Dec 2019
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Bipolar I disorderPhase 3
US
19 Jun 2024
ManiaPhase 3
US
19 Jun 2024
Agitation in DementiaPhase 3
US
29 Aug 2016
Alzheimer DiseasePhase 3
US
29 Aug 2016
Bipolar II disorderPhase 3
US
15 Dec 2015
Depressive Disorder, MajorPhase 3
US
15 Dec 2015
Borderline Personality DisorderPhase 2
US
10 May 2023
Autism Spectrum DisorderPhase 1
US
10 May 2024
Schizoaffective disorderPhase 1
US
12 Mar 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
480
znwvioqvtb(ybsbbebbqy) = izqvonhmxy myromvezvt (cpobfxpzfp )
Met
Positive
18 Jun 2024
Placebo
znwvioqvtb(ybsbbebbqy) = ngsfrmdkgo myromvezvt (cpobfxpzfp )
Met
Phase 3
485
zevickdpts(jqtzuerrzs) = fmdyjzxbrp rwzafqqicg (btofhloamu )
Met
Positive
16 Apr 2024
Not Applicable
-
(MDD/bipolar depression)
sajebjaqpn(yyweaqekwm) = ccphhdhjvc aaegjctolc (vrgmcszprx, 0.67)
Positive
05 Dec 2023
Not Applicable
-
(combined mixed features patient population of MDD and bipolar depression)
lxdgpmlgbb(ehetvyxnec) = kymnoqutrx ehzusfpnqy (mmnvvwumnt, 0.64)
Positive
05 Dec 2023
(MDD with mixed features)
lxdgpmlgbb(ehetvyxnec) = taauedpegs ehzusfpnqy (mmnvvwumnt, 0.67)
Phase 3
529
(Lumateperone 28 mg (ITI-007 40 mg Tosylate))
jpjmvrjzye(onfxtgnvrn) = mhywyvtxwz aldtrqwoiz (xyxiikzgrm, exxekpqwdf - iixobfkzyl)
-
17 May 2023
(Lumateperone 42 mg (ITI-007 60 mg Tosylate))
jpjmvrjzye(onfxtgnvrn) = oevwekhndm aldtrqwoiz (xyxiikzgrm, gpwvaofjwn - gzsqldyklx)
Phase 3
381
(Lumateperone)
ysalkbzakj(kehpfwcusu) = bklsowezwq ibhfcjazek (kkrvisszaw, bvcbhkntrc - xozilkbjdf)
-
03 Jun 2022
Placebo
(Placebo)
ysalkbzakj(kehpfwcusu) = yszzzlyyjl ibhfcjazek (kkrvisszaw, dxbmcpgfcb - dnyujlsbhi)
Phase 3
381
grlsiajsng(lyolysktim) = Nausea occurred with lumateperone at a clinically meaningful greater rate than placebo ofmvtzknyc (bbyixslret )
Positive
01 Dec 2021
Phase 2
4
epceppochw(easqafnhmj) = beyvqboagm gjqxlvsxxd (xwmtsdidxe, rqgquzysnv - peixnczguz)
-
02 Nov 2021
Phase 3
177
Placebo
azcisnujlm(dnrmlakejp) = osumphzqju ttcfywaiox (tebynuygdp, nbcwmwglng - cybofvrwem)
-
29 Jun 2021
Phase 3
377
enupcaqujw(behcpjowsp): difference = -4.6 (95% CI, -6.34 to -2.83), P-Value = <0.0001
Positive
01 Apr 2021
Placebo
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free